Extrahepatic Bile Duct Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - About This PDQ Summary
About PDQPhysician Data Query (PDQ) is the National Cancer Institute's (NCI's) comprehensive cancer information database. The PDQ database contains summaries of the latest published information on cancer prevention, detection, genetics, treatment, supportive care, and complementary and alternative medicine. Most summaries come in two versions. The health professional versions have detailed information written in technical language. The patient versions are written in easy-to-understand, nontechnical language. Both versions have cancer information that is accurate and up to date and most versions are also available in Spanish.PDQ is a service of the NCI. The NCI is part of the National Institutes of Health (NIH). NIH is the federal government's center of biomedical research. The PDQ summaries are based on an independent review of the medical literature. They are not policy statements of the NCI or the NIH.Purpose of This SummaryThis PDQ cancer information summary has current
Penile Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage IV Penile Cancer
Stage IV penile cancer is defined by the following TNM classifications:T4, Any N, M0Any T, N3, M0Any T, Any N, M1No standard treatment exists that is curative for patients with stage IV penile cancer. Therapy is directed at palliation, which may be achieved either with surgery or radiation therapy. Standard treatment options:Palliative surgery may be considered for control of the local penile lesion and even for the prevention of the necrosis, infection, and hemorrhage that can result from neglected regional adenopathy.Radiation therapy may be palliative for the primary tumor, regional adenopathy, and bone metastases.Treatment options under clinical evaluation: Clinical trials combining chemotherapy with palliative methods of local control are appropriate for such patients (tested chemotherapeutic drugs with some efficacy include vincristine, cisplatin, methotrexate, and bleomycin). The combination of vincristine, bleomycin, and methotrexate has been effective both as adjuvant and
Non-Small Cell Lung Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Treatment Options by Stage
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.Occult Non-Small Cell Lung CancerTreatment of occult non-small cell lung cancer depends on the stage of the disease. Occult tumors are often found at an early stage (the tumor is in the lung only) and sometimes can be cured by surgery.Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with occult non-small cell lung cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.Stage 0 (Carcinoma in Situ)Treatment of stage 0 may include the following:Surgery (wedge resection or segmental
Gastric Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Gastric Cancer
Gastric cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. The stomach is a J-shaped organ in the upper abdomen. It is part of the digestive system,which processes nutrients (vitamins,minerals,carbohydrates,fats,proteins,and water) in foods that are eaten and helps pass waste material out of the body. Food moves from the throat to the stomach through ...
Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®): Supportive care - Health Professional Information [NCI] - nci_ncicdr0000062870-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Oral Complications of Chemotherapy and Head/Neck Radiation
Esophageal Cancer Screening (PDQ®): Screening - Patient Information [NCI] - nci_ncicdr0000304521-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Esophageal Cancer Screening
Nasopharyngeal Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Recurrent Nasopharyngeal Cancer
Recurrent nasopharyngeal cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the nasopharynx or in other parts of the body.
Vulvar Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Vulvar Cancer
Vulvar cancer is a rare disease in which malignant (cancer) cells form in the tissues of the vulva. Vulvar cancer forms in a woman's external genitalia. The vulva includes the inner and outer lips of the vagina,the clitoris (sensitive tissue between the lips),and the opening of the vagina and its glands. Vulvar cancer most often affects the outer vaginal lips. Less often,cancer affects the ...
Breast Cancer Treatment (PDQ®): Treatment - Patient Information [NCI] - Changes to This Summary (10 / 24 / 2014)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.Editorial changes were made to this summary.
Antineoplastons (PDQ®): Complementary and alternative medicine - Health Professional Information [NCI] - Summary of the Evidence for Antineoplastons
To assist readers in evaluating the results of human studies of complementary and alternative medicine (CAM) treatments for cancer, the strength of the evidence (i.e., the levels of evidence) associated with each type of treatment is provided whenever possible. To qualify for a level of evidence analysis, a study must:Be published in a peer-reviewed scientific journal.Report on a therapeutic outcome or outcomes, such as tumor response, improvement in survival, or measured improvement in quality of life.Describe clinical findings in sufficient detail that a meaningful evaluation can be made.Antineoplaston therapy has been studied as a complementary and alternative therapy for cancer. Case reports, phase I toxicity studies, and some phase II clinical studies examining the effectiveness of antineoplaston therapy have been published. For the most part, these publications have been authored by the developer of the therapy, Dr. Burzynski, in conjunction with his associates at the Burzynski